Literature DB >> 12881896

Importance of cloud motion on cigarette smoke deposition in lung airways.

T B Martonen1, C J Musante.   

Abstract

Deposition patterns of mainstream cigarette smoke were studied in casts of human extrathoracic and lung airways. The laboratory tests were designed to simulate smoking (i.e., the behavior of undiluted cigarette smoke in smokers' lungs), not secondary exposures to non-smokers. The experimental data revealed concentrated deposits at well-defined sites, particularly at bifurcations (most notably at inclusive carinal ridges) and certain segments of tubular airways. The measurements suggest the occurrence of cloud motion wherein particles are not deposited by their individual characteristics but behave as an entity. The observed behavior is consistent with the theory of Martonen (1992), where it was predicted that cigarette smoke could behave aerodynamically as a large cloud (e.g., 20 microns diameter) rather than as submicrometer constituent particles. The effects of cloud motion on deposition are pronounced. For example, an aerosol with a mass median aerodynamic diameter (MMAD) of 0.443 micron and geometric standard deviation (GSD) of 1.44 (i.e., published cigarette smoke values) will have the following deposition fractions: lung (TB + P) = 0.14, tracheobronchial (TB) = 0.03, and pulmonary (P) = 0.11. When cloud motion is simulated, total deposition increases to 0.99 and is concentrated in the TB compartment, especially the upper bronchi; pulmonary deposition is negligible. Cloud motion produces heterogeneous deposition resulting in increased exposures of underlying airway cells to toxic and carcinogenic substances. The deposition sites correlated with incidence of cancers in vivo. At present, cloud motion concentration effects per se are not addressed in federal regulatory standards. The experimental and theoretical data suggest that concentrations of particulate matter may be an important factor to be integrated into U.S. Environmental Protection Agency (EPA) risk assessment protocols.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12881896     DOI: 10.1080/08958370050165120

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  7 in total

Review 1.  Biomarkers of exposure to new and emerging tobacco delivery products.

Authors:  Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

2.  NIH electronic cigarette workshop: developing a research agenda.

Authors:  Kevin M Walton; David B Abrams; William C Bailey; David Clark; Gregory N Connolly; Mirjana V Djordjevic; Thomas E Eissenberg; Michael C Fiore; Maciej L Goniewicz; Lynne Haverkos; Stephen S Hecht; Jack E Henningfield; John R Hughes; Cheryl A Oncken; Lisa Postow; Jed E Rose; Kay L Wanke; Lucie Yang; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2014-10-21       Impact factor: 4.244

Review 3.  Review: Is lung inflammation associated with microbes and microbial toxins in cigarette tobacco smoke?

Authors:  John L Pauly; Lauren A Smith; Michael H Rickert; Alan Hutson; Geraldine M Paszkiewicz
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

4.  Component-specific, cigarette particle deposition modeling in the human respiratory tract.

Authors:  Bahman Asgharian; Owen T Price; Caner U Yurteri; Colin Dickens; John McAughey
Journal:  Inhal Toxicol       Date:  2013-12-20       Impact factor: 2.724

Review 5.  Nasally inhaled therapeutics and vaccination for COVID-19: Developments and challenges.

Authors:  Jinxiang Xi; Lameng Ray Lei; William Zouzas; Xiuhua April Si
Journal:  MedComm (2020)       Date:  2021-12-14

Review 6.  International issues on human health effects of exposure to chemical mixtures.

Authors:  Victor J Feron; Flemming R Cassee; John P Groten; Petronella W van Vliet; Job A van Zorge
Journal:  Environ Health Perspect       Date:  2002-12       Impact factor: 9.031

Review 7.  Lung deposition analyses of inhaled toxic aerosols in conventional and less harmful cigarette smoke: a review.

Authors:  Clement Kleinstreuer; Yu Feng
Journal:  Int J Environ Res Public Health       Date:  2013-09-23       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.